We just received data on a new analyst forecast for $DNLI. Laura Chico from Wedbush set a price target of 31.0 for DNLI.
To track analyst ratings and price targets for $DNLI, check out Quiver Quantitative's $DNLI forecast page.
Should you buy $DNLI?
Some analysts are better than others. To view the past performance of Wedbush, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$DNLI Price Targets
Multiple analysts have issued price targets for $DNLI recently. We have seen 4 analysts offer price targets for $DNLI in the last 6 months, with a median target of $30.5.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $32.0 on 12/05/2025
- Laura Chico from Wedbush set a target price of $31.0 on 12/05/2025
- Jessica Fye from JP Morgan set a target price of $26.0 on 11/04/2025
- Matthew Harrison from Morgan Stanley set a target price of $30.0 on 08/18/2025
$DNLI Insider Trading Activity
$DNLI insiders have traded $DNLI stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $DNLI stock by insiders over the last 6 months:
- RYAN J. WATTS (President and CEO) sold 495,282 shares for an estimated $7,429,230
- CAROLE HO (Chief Medical Officer) has made 0 purchases and 2 sales selling 3,743 shares for an estimated $51,684.
- ALEXANDER O. SCHUTH (COFO and Secretary) sold 2,937 shares for an estimated $39,884
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DNLI Hedge Fund Activity
We have seen 127 institutional investors add shares of $DNLI stock to their portfolio, and 118 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 5,605,499 shares (-99.0%) from their portfolio in Q3 2025, for an estimated $81,391,845
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 4,667,797 shares (+74.5%) to their portfolio in Q3 2025, for an estimated $67,776,412
- NORGES BANK added 2,881,779 shares (+270.4%) to their portfolio in Q2 2025, for an estimated $40,316,088
- HOLOCENE ADVISORS, LP added 2,732,540 shares (+677.8%) to their portfolio in Q3 2025, for an estimated $39,676,480
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,391,633 shares (+73.7%) to their portfolio in Q3 2025, for an estimated $34,726,511
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,013,927 shares (-30.6%) from their portfolio in Q3 2025, for an estimated $29,242,220
- FMR LLC removed 1,198,152 shares (-15.9%) from their portfolio in Q3 2025, for an estimated $17,397,167
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
